PTEN regulates PLK1 and controls chromosomal stability during cell division

References

• Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 2005; 7:193-204; PMID:15710331; http://dx.doi.org/10.1016/j.ccr.2005.01.009
   PubMed Web of Science ®Google Scholar
• Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128:157-70; PMID:17218262; http://dx.doi.org/10.1016/j.cell.2006.11.042
   PubMed Web of Science ®Google Scholar
• Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna I, et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447:966-71; PMID:17515920; http://dx.doi.org/10.1038/nature05886
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Worley L, Onken MD, Harbour JW. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 2008; 14:115-22; PMID:18172260; http://dx.doi.org/10.1158/1078-0432.CCR-07-1825
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96:4240-5; PMID:10200246; http://dx.doi.org/10.1073/pnas.96.8.4240
   PubMed Web of Science ®Google Scholar
• Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004; 15:171-6; PMID:15209376; http://dx.doi.org/10.1016/j.semcdb.2003.12.021
   PubMed Web of Science ®Google Scholar
• Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4:127-50; PMID:18767981; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092311
   PubMed Web of Science ®Google Scholar
• Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M, Pandolfi PP. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 2011; 144:187-99; PMID:21241890; http://dx.doi.org/10.1016/j.cell.2010.12.020
   PubMed Web of Science ®Google Scholar
• Bassi C, Ho J, Srikumar T, Dowling RJ, Gorrini C, Miller SJ, Mak TW, Neel BG, Raught B, Stambolic V. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 2013; 341:395-9; PMID:23888040; http://dx.doi.org/10.1126/science.1236188
   PubMed Web of Science ®Google Scholar
• Chen ZH, Zhu M, Yang J, Liang H, He J, He S, Wang P, Kang X, McNutt MA, Yin Y, et al. PTEN interacts with histone H1 and controls chromatin condensation. Cell reports 2014; 8:2003-14; PMID:25199838; http://dx.doi.org/10.1016/j.celrep.2014.08.008
   PubMed Web of Science ®Google Scholar
• Gong L, Govan JM, Evans EB, Dai H, Wang E, Lee SW, Lin HK, Lazar AJ, Mills GB, Lin SY. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure. Cell Cycle 2015; 14:2323-32; PMID:25946202; http://dx.doi.org/10.1080/15384101.2015.1044174
   PubMed Web of Science ®Google Scholar
• He J, Kang X, Yin Y, Chao KS, Shen WH. PTEN regulates DNA replication progression and stalled fork recovery. Nat Commun 2015; 6:7620; PMID:26158445; http://dx.doi.org/10.1038/ncomms8620
   PubMed Web of Science ®Google Scholar
• Kang X, Song C, Du X, Zhang C, Liu Y, Liang L, He J, Lamb K, Shen WH, Yin Y. PTEN stabilizes TOP2A and regulates the DNA decatenation. Sci Rep 2015; 5:17873; PMID:26657567; http://dx.doi.org/10.1038/srep17873
   PubMed Web of Science ®Google Scholar
• Yu S, Yang F, Shen WH. Genome maintenance in the context of 4D chromatin condensation. Cell Mol Life Sci: CMLS 2016; 73:3137-150; PMID:27098512; http://dx.doi.org/10.1007/s00018-016-2221-2
   Web of Science ®Google Scholar
• Baker SJ. PTEN enters the nuclear age. Cell 2007; 128:25-8; PMID:17218252; http://dx.doi.org/10.1016/j.cell.2006.12.023
   PubMed Web of Science ®Google Scholar
• Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008; 27:5443-53; PMID:18794879; http://dx.doi.org/10.1038/onc.2008.241
   PubMed Web of Science ®Google Scholar
• Saal LH, Gruvberger-Saal SK, Persson C, Lovgren K, Jumppanen M, Staaf J, Jonsson G, Pires MM, Maurer M, Holm K, et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008; 40:102-7; PMID:18066063; http://dx.doi.org/10.1038/ng.2007.39
   PubMed Web of Science ®Google Scholar
• Sun Z, Huang C, He J, Lamb KL, Kang X, Gu T, Shen WH, Yin Y. PTEN C-terminal deletion causes genomic instability and tumor development. Cell Rep 2014; 6:844-54; PMID:24561254; http://dx.doi.org/10.1016/j.celrep.2014.01.030
   PubMed Web of Science ®Google Scholar
• Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17:157-62; PMID:17324569; http://dx.doi.org/10.1016/j.gde.2007.02.011
   PubMed Web of Science ®Google Scholar
• Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 2004; 5:45-54; PMID:14708009; http://dx.doi.org/10.1038/nrm1276
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437:1043-7; PMID:16222300; http://dx.doi.org/10.1038/nature04217
   PubMed Web of Science ®Google Scholar
• Storchova Z, Breneman A, Cande J, Dunn J, Burbank K, O'Toole E, Pellman D. Genome-wide genetic analysis of polyploidy in yeast. Nature 2006; 443:541-7; PMID:17024086; http://dx.doi.org/10.1038/nature05178
   PubMed Web of Science ®Google Scholar
• Sunkel CE, Glover DM. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 1988; 89(Pt 1):25-38; PMID:3417791
   PubMed Web of Science ®Google Scholar
• Ohkura H, Hagan IM, Glover DM. The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells. Genes Dev 1995; 9:1059-73; PMID:7744248; http://dx.doi.org/10.1101/gad.9.9.1059
   PubMed Web of Science ®Google Scholar
• Hartwell LH, Mortimer RK, Culotti J, Culotti M. Genetic control of the cell division cycle in yeast: V. genetic analysis of cdc mutants. Genetics 1973; 74:267-86; PMID:17248617
   PubMed Web of Science ®Google Scholar
• Qian YW, Erikson E, Li C, Maller JL. Activated polo-like kinase Plx1 is required at multiple points during mitosis in Xenopus laevis. Mol Cell Biol 1998; 18:4262-71; PMID:9632810; http://dx.doi.org/10.1128/MCB.18.7.4262
   PubMed Web of Science ®Google Scholar
• Stegmeier F, Visintin R, Amon A. Separase, polo kinase, the kinetochore protein Slk19, and Spo12 function in a network that controls Cdc14 localization during early anaphase. Cell 2002; 108:207-20; PMID:11832211; http://dx.doi.org/10.1016/S0092-8674(02)00618-9
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kono K, Lowery DM, Bartolini S, Yaffe MB, Ohya Y, Pellman D. Polo-like kinase Cdc5 controls the local activation of Rho1 to promote cytokinesis. Science 2006; 313:108-11; PMID:16763112; http://dx.doi.org/10.1126/science.1126747
   PubMed Web of Science ®Google Scholar
• Petronczki M, Glotzer M, Kraut N, Peters JM. Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Dev Cell 2007; 12:713-25; PMID:17488623; http://dx.doi.org/10.1016/j.devcel.2007.03.013
   PubMed Web of Science ®Google Scholar
• Burkard ME, Randall CL, Larochelle S, Zhang C, Shokat KM, Fisher RP, Jallepalli PV. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc Natl Acad Sci U S A 2007; 104:4383-8; PMID:17360533; http://dx.doi.org/10.1073/pnas.0701140104
   PubMed Web of Science ®Google Scholar
• Brennan IM, Peters U, Kapoor TM, Straight AF. Polo-like kinase controls vertebrate spindle elongation and cytokinesis. PLoS One 2007; 2:e409; PMID:17476331; http://dx.doi.org/10.1371/journal.pone.0000409
   PubMed Web of Science ®Google Scholar
• Eckerdt F, Yuan J, Strebhardt K. Polo-like kinases and oncogenesis. Oncogene 2005; 24:267-76; PMID:15640842; http://dx.doi.org/10.1038/sj.onc.1208273
   PubMed Web of Science ®Google Scholar
• Qian YW, Erikson E, Maller JL. Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1. Mol Cell Biol 1999; 19:8625-32; PMID:10567586; http://dx.doi.org/10.1128/MCB.19.12.8625
   PubMed Web of Science ®Google Scholar
• Alexandru G, Uhlmann F, Mechtler K, Poupart MA, Nasmyth K. Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast. Cell 2001; 105:459-72; PMID:11371343; http://dx.doi.org/10.1016/S0092-8674(01)00362-2
   PubMed Web of Science ®Google Scholar
• Carmena M, Riparbelli MG, Minestrini G, Tavares AM, Adams R, Callaini G, Glover DM. Drosophila polo kinase is required for cytokinesis. J Cell Biol 1998; 143:659-71; PMID:9813088; http://dx.doi.org/10.1083/jcb.143.3.659
   PubMed Web of Science ®Google Scholar
• Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R. Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol 2002; 29:354-8; PMID:12135466; http://dx.doi.org/10.1034/j.1600-0560.2002.290605.x
   PubMed Web of Science ®Google Scholar
• Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rubsamen-Waigmann H, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997; 14:543-9; PMID:9053852; http://dx.doi.org/10.1038/sj.onc.1200862
   PubMed Web of Science ®Google Scholar
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett 2001; 164:41-9; PMID:11166914; http://dx.doi.org/10.1016/S0304-3835(00)00703-5
   PubMed Web of Science ®Google Scholar
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Polo-like kinase (PLK) expression in endometrial carcinoma. Cancer Lett 2001; 169:41-9; PMID:11410324; http://dx.doi.org/10.1016/S0304-3835(01)00522-5
   PubMed Web of Science ®Google Scholar
• Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 1999; 59:2794-7; PMID:10383133
   PubMed Web of Science ®Google Scholar
• Kelm O, Wind M, Lehmann WD, Nigg EA. Cell cycle-regulated phosphorylation of the Xenopus polo-like kinase Plx1. J Biol Chem 2002; 277:25247-56; PMID:11994303; http://dx.doi.org/10.1074/jbc.M202855200
   PubMed Web of Science ®Google Scholar
• Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL, Ferris DK. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem 1995; 270:21086-91; PMID:7673138; http://dx.doi.org/10.1074/jbc.270.36.21086
   PubMed Web of Science ®Google Scholar
• Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, Clouin C, Taylor SS, Yaffe MB, Medema RH. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455:119-23; PMID:18615013; http://dx.doi.org/10.1038/nature07185
   PubMed Web of Science ®Google Scholar
• Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008; 320:1655-8; PMID:18566290; http://dx.doi.org/10.1126/science.1157425
   PubMed Web of Science ®Google Scholar
• Jang YJ, Ma S, Terada Y, Erikson RL. Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem 2002; 277:44115-20; PMID:12207013; http://dx.doi.org/10.1074/jbc.M202172200
   PubMed Web of Science ®Google Scholar
• Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441:475-82; PMID:16598206; http://dx.doi.org/10.1038/nature04703
   PubMed Web of Science ®Google Scholar
• Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela-Arispe ML, Varella-Garcia M, et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008; 453:529-33; PMID:18463637; http://dx.doi.org/10.1038/nature06933
   PubMed Web of Science ®Google Scholar
• Guo W, Schubbert S, Chen JY, Valamehr B, Mosessian S, Shi H, Dang NH, Garcia C, Theodoro MF, Varella-Garcia M, et al. Suppression of leukemia development caused by PTEN loss. Proc Natl Acad Sci U S A 2011; 108:1409-14; PMID:21212363; http://dx.doi.org/10.1073/pnas.1006937108
   PubMed Web of Science ®Google Scholar
• Lee KS, Erikson RL. Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol Cell Biol 1997; 17:3408-17; PMID:9154840; http://dx.doi.org/10.1128/MCB.17.6.3408
   PubMed Web of Science ®Google Scholar
• Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, Salmena L, Sampieri K, Haveman WJ, Brogi E, et al. Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 2010; 42:454-8; PMID:20400965; http://dx.doi.org/10.1038/ng.556
   PubMed Web of Science ®Google Scholar
• Shen-Li H, Koujak S, Szablocs M, Parsons R. Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice. Cancer Biol Ther 2010; 10:1194-200; PMID:20980828; http://dx.doi.org/10.4161/cbt.10.11.13814
   PubMed Web of Science ®Google Scholar
• Sulis ML, Parsons R. PTEN: from pathology to biology. Trends Cell Biol 2003; 13:478-83; PMID:12946627; http://dx.doi.org/10.1016/S0962-8924(03)00175-2
   PubMed Web of Science ®Google Scholar
• Tamguney T, Stokoe D. New insights into PTEN. J Cell Sci 2007; 120:4071-9; PMID:18032782; http://dx.doi.org/10.1242/jcs.015230
   PubMed Web of Science ®Google Scholar
• Zhou T, Aumais JP, Liu X, Yu-Lee LY, Erikson RL. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell 2003; 5:127-38; PMID:12852857; http://dx.doi.org/10.1016/S1534-5807(03)00186-2
   PubMed Web of Science ®Google Scholar
• Gu T, Zhang Z, Wang J, Guo J, Shen WH, Yin Y. CREB is a novel nuclear target of PTEN phosphatase. Cancer Res 2011; 71:2821-5; PMID:21385900; http://dx.doi.org/10.1158/0008-5472.CAN-10-3399
   PubMed Web of Science ®Google Scholar
• Tibarewal P, Zilidis G, Spinelli L, Schurch N, Maccario H, Gray A, Perera NM, Davidson L, Barton GJ, Leslie NR. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci Signaling 2012; 5:ra18; PMID:22375056; http://dx.doi.org/10.1126/scisignal.2002138
   PubMed Web of Science ®Google Scholar
• Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997; 6:1383-7; PMID:9259288; http://dx.doi.org/10.1093/hmg/6.8.1383
   PubMed Web of Science ®Google Scholar
• Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16:64-7; PMID:9140396; http://dx.doi.org/10.1038/ng0597-64
   PubMed Web of Science ®Google Scholar
• Holt LJ. Regulatory modules: Coupling protein stability to phopshoregulation during cell division. FEBS Lett 2012; 586:2773-7; PMID:22664379; http://dx.doi.org/10.1016/j.febslet.2012.05.045
   PubMed Web of Science ®Google Scholar
• Lenart P, Petronczki M, Steegmaier M, Di Fiore B, Lipp JJ, Hoffmann M, Rettig WJ, Kraut N, Peters JM. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr Biol 2007; 17:304-15; PMID:17291761; http://dx.doi.org/10.1016/j.cub.2006.12.046
   PubMed Web of Science ®Google Scholar
• Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M, Gurtler U, Garin-Chesa P, Lieb S, Quant J, et al. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 2007; 17:316-22; PMID:17291758; http://dx.doi.org/10.1016/j.cub.2006.12.037
   PubMed Web of Science ®Google Scholar
• Liu XS, Song B, Elzey BD, Ratliff TL, Konieczny SF, Cheng L, Ahmad N, Liu X. Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation. J Biol Chem 2011; 286:35795-800; PMID:21890624; http://dx.doi.org/10.1074/jbc.C111.269050
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Bi P, Lu Y, Burcham G, Elzey BD, Ratliff T, Konieczny SF, Ahmad N, Kuang S, et al. Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state. Mol Cell Biol 2014; 34:3642-61; PMID:25047839; http://dx.doi.org/10.1128/MCB.00814-14
   PubMed Web of Science ®Google Scholar
• Choi BH, Pagano M, Dai W. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle. J Biol Chem 2014; 289:14066-74; PMID:24706748; http://dx.doi.org/10.1074/jbc.M114.558155
   PubMed Web of Science ®Google Scholar
• Sagona AP, Nezis IP, Pedersen NM, Liestol K, Poulton J, Rusten TE, Skotheim RI, Raiborg C, Stenmark H. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol 2010; 12:362-71; PMID:20208530; http://dx.doi.org/10.1038/ncb2036
   PubMed Web of Science ®Google Scholar
• Bolanos-Garcia VM. Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies. Curr Cancer Drug Targets 2009; 9:131-41; PMID:19275754; http://dx.doi.org/10.2174/156800909787580980
   PubMed Web of Science ®Google Scholar
• Huang HC, Shi J, Orth JD, Mitchison TJ. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 2009; 16:347-58; PMID:19800579; http://dx.doi.org/10.1016/j.ccr.2009.08.020
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell 2008; 133:612-26; PMID:18485870; http://dx.doi.org/10.1016/j.cell.2008.03.025
   PubMed Web of Science ®Google Scholar